This study aimed to determine the physicians' knowledge and demographic associations regarding GLP-1 RA, DPP-4i, and SGLT-2i medication for the management of T2DM, focusing on their understanding of indications, contraindications, complications, and patient selection criteria. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.